| INTRODUCTION
Prediabetes, the precursor to type 2 diabetes (T2DM), has become a silent threat with 79 million individuals affected in the USA-three times higher than the number of individuals with T2DM. 1 Therefore, the prevention of prediabetes is essential to reduce the number of individuals developing T2DM and its associated serious complications.
Periodontitis is a chronic inflammatory disease, which destroys gingiva and alveolar bone over an extended period of time and is mediated by a host cell response to invading bacteria. 2 These bacteria are disseminated to different sites of the body such as the liver, 3 aorta 4 and atherosclerotic plaque 5, 6 via the systemic circulation as well as via host cells such as myeloid dendritic cells. 6, 7 However, the mechanisms by which periodontal pathogens influence the development of systemic diseases such as insulin resistance (IR) and prediabetes have yet to be clarified.
Results from our previous studies indicated that hyperinsulinemia developed when periodontitis was induced in rats and mice. [8] [9] [10] As the pancreatic β cell is the only known source of circulating insulin, these data suggest that periodontitis influences insulin secretion by stimulating pancreatic β cells. To extend these findings, we investigated the effect of the periodontal pathogen, Porphyromonas gingivalis (Pg), on insulin secretion by the β-cell line MIN6 11 and demonstrated that upregulation of insulin secretion by these cells was mediated by SerpinE1, also known as plasminogen activator inhibitor 1 or PAI1.
12
SerpinE1 is a serine protease inhibitor that inhibits tissue type plasminogen activators (tPA) and urokinase plasminogen activators (uPA), thus its primary function is antifibrinolytic. However, SerpinE1 also regulates cell migration. 13 Owing to its antifibrinolytic activity, increased levels of SerpinE1 are thought to lead to the development of atherosclerosis and atherothrombosis. 14, 15 SerpinE1 is associated with cardiovascular diseases and metabolic syndrome, 16 including IR, obesity and diabetes. 17 It has also been reported that subjects with periodontitis have higher concentrations of circulating SerpinE1 compared with periodontally healthy subjects. 18 However, the functional role of this increase in SerpinE1 in subjects with periodontitis has yet to be determined.
Hyperinsulinemia occurs in prediabetes. It is generally accepted that hyperinsulinemia is caused by overproduction of insulin by pancreatic β cells to compensate for IR in the insulin target organs.
Stressed β cells eventually fatigue and die by apoptosis. 19 Thus, pancreatic β-cell apoptosis can ultimately lead to frank T2DM. This significant decrease in functional β cells is a cardinal feature of T2DM.
However, the factors that initiate apoptosis are just beginning to be described. 20 As SerpinE1 promotes insulin secretion in MIN6 cells when cells are exposed to Pg-lipopolysaccharide (Pg-LPS), 12 we hypothesized that SerpinE1 may function in the induction of hyperinsulinemia and/ or β-cell apoptosis. To test this hypothesis, we investigated SerpinE1 involvement in apoptosis in MIN6 cells exposed to Pg.
To understand the biological relevance of Pg on pancreatic islets in vivo, we induced chronic periodontitis by oral application of Pg in mice 10 and analyzed changes that occurred in islet morphology with respect to α and β cells. Understanding mechanisms by which these changes occur will help determine how to modulate the induction of the prediabetic condition triggered by periodontitis.
| MATERIAL AND METHODS

| MIN6 cell culture
MIN6 cells (passages [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] were grown in Dulbecco's modified
Eagle's medium (containing 25 mm glucose, 10% fetal bovine serum, 4 mm l-glutamine, 1 mm sodium pyruvate, 0.1 mg/mL penicillin/streptomycin and 2 μL of 2-mercaptoethanol/L media). Cells were incubated at 37°C in a 5% CO 2 humidified incubator. The culture medium was changed every 3-4 days and cells passaged once a week.
| P. gingivalis culture
Pg (strain W83) was grown anaerobically (85% N 2 , 10% H 2 and 5%
CO 2 ) in GasPak anaerobic containers (BD Bioscience, Franklin Lakes, NJ, USA) using GasPak EZ pouches (BD Bioscience) at 37°C according to the methodology described by Bhat and Watanabe. 
| Western blotting
Western blot analysis was performed using the protocol described by Watanabe et al. 9 Briefly, cells were washed with ice-cold phosphatebuffered saline (PBS) and lysed with RIPA buffer (50 mm Tris-HCl, 
| TUNEL assay for in situ apoptosis detection
Mid-log MIN6 cells were plated at a density of 5×10 four independent experiments) using a Leica DM-750 microscope.
TUNEL detection of apoptosing cells in pancreatic islets from the experimental (E) and control (C) groups was performed by immunofluorescence microscopy using the TdT In Situ Apoptosis Detection Kit (Roche Diagnostics) according to the manufacturer's protocol. β cells were detected as described below.
| Experimental periodontitis by oral application of P. gingivalis in mice
Experiments were carried out in strict accordance with the recom- 
| Immunofluorescence microscopy
Immunofluorescence microscopy was performed for the detection of insulin (β-cell marker), SerpinE1, glucagon (α cell marker), nuclei (DAPI) and Pg/gingipain using samples as follows. 
| Statistical analysis
Statistical analysis was performed using a paired Student's t-test with a significance level of P<.05. 3-D analysis was performed by co-localization of staining determined with thresholded Mander's coefficients. 21 
| RESULTS
| P. gingivalis and/or gingipains were detected at periodontitis sites as well as in the pancreas of the experimental group but not the control group
Pg produces cysteine proteases, gingipains, which are located on the outer membranes. These are known to degrade a variety of host proteins involved in host defense. 22 The presence of the Pg/gingipain epitope was detected by immunofluorescence microscopy using a monoclonal antibody 61BG1.3 (DSHB) specific to an epitope in gingipain 23 in periodontal tissues (Fig. 1A b) and pancreata (Fig. 1B b) of the experimental group, but not in the control group (Fig. 1A a, B a) .
Pg and/or gingipain were present in both pancreatic islets and parenchyma of the experimental group, but not in the control group (Fig. 1B) .
| Oral application of P. gingivalis results in upregulation of SerpinE1 and changes in islet architecture
Results from immunofluorescence microscopy of islets indicated that the number of cells expressing SerpinE1 was significantly higher in the experimental group compared with the control group ( Fig. 2A) .
Competing peptide analysis with SerpinE1-specific blocking peptide indicated that the primary polyclonal antibody to SerpinE1 was specific for SerpinE1 (data not shown). Furthermore, there was a significant alteration in the architecture of islets in the experimental group compared with controls. In control animals, α cells (defined by glucagon staining) were located in the mantle zone, which surrounds the β-cell core (Fig. 2B a) . However, in the experimental group, α cells were found inside the β-cell core as well as in the mantle zone (Fig. 2B b) . SerpinE1 expression was minimal if any in the control group in the mantle zone as well as the β-cell core (Fig. 2C a, d ). However, SerpinE1 expression was significantly higher in the α cells in the mantle zone (Fig. 2C b, c ) and β cells in the β-cell core (Fig. 2C e, f) in islets from the experimental group compared with control group. This result is depicted by 3-D capture of glucagon, insulin and SerpinE1 staining (Fig. 2D ).
| Alpha cells but not beta cells express urokinase plasminogen activator, a target of SerpinE1, in animals with oral application of P. gingivalis
SerpinE1, when complexed with its substrate uPA, functions in cell migration. 13 Thus, we investigated the pattern of uPA expression in islets. We observed that uPA was expressed in α cells (Fig. 3A a, b ),
but not β cells (Fig. 3A , β-cell core insets). There was a significantly (Fig. 3B b) compared with the control group (Fig. 3B a, c), and these co-expressing cells were α cells based on co-staining with glucagon ( Fig. 3A c) .
| Beta-cell apoptosis is evident in islets of animals with oral application of P. gingivalis
To determine if cells in pancreatic islets of animals in the experimental group undergo apoptosis relative to control animals, we examined islets using immunofluorescence microscopy TUNEL assays (Fig. 4A a, b) . We observed significant numbers of apoptotic cells in islets of the experimental group but not in the control group (Fig. 4A, B) . These apoptotic cells were primarily β cells as indicated by insulin staining in the β-cell core (Fig. 4A b) . The number of apoptotic β cells is significantly higher in the experimental group compared with the control group (Fig 4B) .
| P. gingivalis induces apoptosis of β cells via both intrinsic and extrinsic pathways in vitro and downregulation of SerpinE1 reduces MIN6 cell apoptosis
To determine the direct effects of Pg on apoptosis of β cells, we per- Image acquired by Imaris ×64. Number of islet cells (pixel) co-expressing glucagon and SerpinE1 is statistically higher in the experimental group compared with the control group (P<.00001) (determined by t test using Mander's coefficient). Representative of n=5 animals/group. Scale: 60 μm shRNA (clone C) MIN6 cells 12 and determined the extent of apoptosis following exposure to Pg (Fig. 5D ). TUNEL staining of control clone C and clone 23 indicated that cells with SerpinE1 knockdown are less susceptible to Pg-induced apoptosis 24 hours after Pg addition.
| DISCUSSION
In our previous studies, we used application of LPS to the gingival sulci, 24 placement of silk sutures with application of LPS 8 and oral application of Pg. 10 In each of these model systems, we detected alveolar bone loss and all animals (experimental group) developed prediabetes.
In the current study, we focused on the effect of oral application of Pg on the pancreas as this organ is the body's only source of circulating insulin and is critical in maintaining normal glucose levels. 19 We previously reported that SerpinE1 was expressed in the MIN6 pancreatic β cell line in vitro and expression levels were significantly higher upon incubation of cells with Pg-LPS or live Pg. 11, 12 The results from the current in vivo study demonstrated that SerpinE1 was minimally expressed in the islets of the control group but was highly expressed in the experimental group, supporting the results from our in vitro study. As shown by 2-D and 3-D image analyses, SerpinE1 expression was upregulated not only in β cells but also in the majority of α cells in the experimental group.
One of the targets of SerpinE1 is uPA and SerpinE1 bound to uPA is known to function in cell migration. 13 We therefore examined uPA It is generally accepted that β cells proliferate in order to secrete more insulin to compensate for peripheral IR. Eventually these cells apoptose during the prediabetic, β-cell compensatory phase. 19 This loss of functional β cells leads to frank T2DM. However, this concept has been recently challenged 25 as near complete β-cell specific destruction resulted in α cell proliferation followed by trans-differentiation of α to β cells. 26 This showed a hitherto unknown plasticity of adult α cells. However, signals mediating this α-to β-cell conversion are still unknown. We determined that animals administered Pg developed hyperinsulinemia, which could be explained by α-to β-cell transdifferentiation, 26 exocytosis of insulin containing vesicles during apoptosis and/or hyperproduction of insulin by preapoptotic β cells.
To our knowledge, we are the first to report unique islet morpho- There are variations in the experimental methodology in the oral application of Pg to induce periodontitis. It has been reported that bone loss varies depending on the strain of Pg used 30 and the duration of Pg application. 31, 32 To study the effects of oral application of Pg on alveolar bone loss, short-term application may be justified.
However, to investigate the systemic effects of periodontitis/pathogen, a prolonged exposure to Pg to develop chronic periodontitis and/ or repeated dosing of bacteria/bacteremia may be necessary. 33 The concept of a life-course chronicity/epidemiology is critical when diseases such as prediabetes and T2DM are studied. In contrast to acute bacterial infections, which are resolved relatively quickly, the effects on target organs from repeated exposure to bacteria and their products, as occurs during periodontitis, may be cumulative and may have a critical role on the development of chronic disease in later life. The development of periodontitis and diabetes takes years or decades. Thus, the concept of chronic disease or life-course chronicity/ epidemiology involving repeated exposure to risk/etiological factors is an important consideration. 34 One such example is smoking and the development of oral cancer, which has a dose-response effect (frequency of exposure). 35 Another example is the effect of smoking on an individual's health later in life (life-course study) as shown by North et al. 36 These studies showed that chronic repeated exposure to risk factors/etiological factors can cause disease in distant organs later in life and are relevant to our model in which repeated exposure to Pg was extended over 22 weeks.
Regular mastication, brushing and flossing expose the host to bacterial products repeatedly throughout life. 37 The incidence and intensity of bacteremia associated with these processes increases with the severity of periodontitis and is via inflamed and ulcerated periodontal pockets next to the subgingival biofilm. 38, 39 This increase in bacterial numbers during periodontal infection collectively results in repeated exposure of distant organs such as the pancreas to bacteria and their (by)products. The pancreas receives blood via the celiac and superior mesenteric arteries, which are oxygenated but unfiltered by the liver.
Thus, vital organs including the pancreas distant from periodontal tissues are repeatedly exposed to the periodontal microbiota and their products throughout life. This exposure provides a cogent mechanistic link between periodontal disease and the variety of systemic diseases with which periodontitis has been associated. 40, 41 Recent animal studies using ApoE −/− mice indicated that orally applied Pg can be translocated to different sites of the body including the liver, aorta, heart and brain. 31, 33, 42 In addition, a change in gut microbiota has been reported in C57BL mice following oral application of Pg. 32 We here show that Pg and/or gingipain was detected in the pancreas of the experimental group and appeared to contribute to changes in both β-cell survival and α-cell migration resulting in islet disorganization.
In conclusion, this study has identified several significant changes that occur in the pancreas subsequent to oral application of Pg. These include alterations of pancreatic islet architecture, upregulation of SerpinE1 associated with islet cells (particularly α cells), hyperinsulinemia and β-cell apoptosis. All these events occurred while normoglycemia was maintained. A limitation of this study is that a single (albeit prototypical) pathogen was used to induce periodontitis, a disease characterized by a complex and not fully characterized microflora. Further studies will be necessary to determine if the use of more representative samples of periodontal microflora may hasten islet disorganization. In addition, it will be of significant clinical interest to determine if inhibition of SerpinE1 prevents or slows islet disorganization and subsequent development of prediabetes in the animal model system.
